-    -    -    -     -    -    -    -     -    -    -    -     -    -    -    -    
Hearing Loss Products and Services
Advertise on Hearing Loss Web
Search This Site or the Web

Free Email Newsletter

Jobs, Jobs, Jobs

Hearing Loss Web Banner
Discussion Forum
In the News!
Last Update: May 4
-    -    -    -     -    -    -    -     -    -    -    -     -    -    -    -    
 
Home
About Us
Search
New to Hearing Loss?
In the News
Discussion Forum
HOH-LD-News
Advertise
Contact Us
Glossary
 
Events
 
Issues
Access
Oral Communications
Emergency Planning
Employment
Family
Hearing Aid Affordability
Identity
Law Enforcement
Psychological
Services
 
Medical
Audiology
Causes
Cures
Meniere's Disease
Tinnitus
 
Local Resources
 
Employment Opportunities
Education Opportunities
Hearing Loss Products and Services
Advocates and Legal
Captioning
Government
Hearing Aids
Hearing Aid Batteries
Hearing Aid Repair
Hearing Dogs
Hearing Loss Organizations
Hints and Tips
Publications
 
Technology
Alerting Devices
Assistive Listening Devices
Cochlear Implants
Hearing Aids
Speech Recognition
Telephones
Two Way Pagers
TTYs (TDDs)
Visual Communications
Links

Most Acoustic Neuroma Surgeries Have Favorable Outcomes

December 2010

Surgery to remove tumors under the brain known as acoustic neuromas produces favorable outcomes in the "vast majority" of patients, according to a study from Loyola University Hospital surgeons Douglas Anderson, MD, and John Leonetti, MD.

An acoustic neuroma, also known as a vestibular schwannoma, is a slow-growing, usually benign, tumor, located behind the ear on the nerve that connects the ear to the brain. The tumor can cause hearing loss in one ear and paralysis on one side of the face. If the tumor grows large enough, it can be fatal. Treatment options include microsurgery (surgery with a microscope), radiation or simply keeping a watchful eye on the tumor.

For their study, Anderson and Leonetti followed 730 patients whom they had jointly operated on during a 21-year period. Patients ranged in age from 9 to 79, with a median age of 48. The average clinical follow-up was 32 months.

Leonetti and Anderson work as a team, with Leonetti gaining access to the tumor and Anderson removing it. If the patient still retains hearing, Leonetti uses one of two surgical techniques, called the retrosigmoid approach or the middle fossa approach. If the patient has lost all hearing, Leonetti uses a technique called the translabyrinthine approach.

Every patient survived the surgery, and the surgeons were able to completely remove the tumors in 95.1 percent of the patients. Ninety percent of patients experienced little or no facial paralysis. And among those who still retained hearing in the affected ear before surgery, 44 percent came out of the surgery with useful hearing in that ear, and 63 percent had at least some hearing.

In the study, the average tumor diameter was 2.2 cm, and 89.5 percent of patients had experienced partial or complete loss of hearing in one ear. Other presurgery symptoms included tinnitus (43.7 percent of patients), dizziness/imbalance (26.8 percent), facial numbness (11.1 percent), headache (10.3 percent) and facial weakness (2.6 percent).

The study results were recently presented at the 2010 Congress of Neurological Surgeons, which awarded Anderson the prestigious Synthes Skull Base Surgery Award.

Other co-authors of the study are Dr. Edward Perry, a resident in neurological surgery and Marc Pisansky, a research assistant.

SOURCE: Loyola University Hospital